PD66-05 DEVELOPMENT AND VALIDATION OF A HEMATURIA CANCER RISK SCORE TO IDENTIFY PATIENTS AT RISK OF HARBOURING CANCER
Wei Shen Tan, John Kelly, Amar Ahmad(Cancer Research UK), Andrew Feber, Sharon Waisbrod, Thomas Hermanns(University of Cologne), Jo Cresswell, Peter Sasieni(Queen Mary University of London), Hugh Mostafid, Christian D. Fankhauser(University of Zurich)
Cited by 0
Related Papers
A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy
|New England Journal of Medicine|2019|1.5k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
|The Lancet Oncology|2019|1k
From Genotypes to Genes: Doubling the Sample Size
|Biometrics|1997|905
Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy
|Journal of Allergy and Clinical Immunology|2008|831